Shah Rajeev M.: insider buys
Every open-market stock purchase reported by Shah Rajeev M. to the SEC on Form 4.
Total bought$61.18M
Purchases3
Companies3
Last purchase filedJul 14, 2026
Return on these buys+104%
Shah Rajeev M. has made 3 open-market purchases worth $61.18M in 3 companies since Mar 31, 2026, according to SEC Form 4 filings. The most recent was filed on Jul 14, 2026: 21,654 shares of ARTV at $8.96 (Director, 10% Owner), worth $194.04K. The largest was $52.22M of COAG on May 4, 2026. Taken together, these purchases are up 104% at the latest closing prices (split-adjusted, weighted by amount).
Companies Shah Rajeev M. bought
| Ticker | Company | Role | Buys | Total | Since buy | Last filed |
|---|---|---|---|---|---|---|
| COAG | Hemab Therapeutics Holdings, Inc. | Director, 10% Owner | 1 | $52.22M | +125% | May 6 |
| MLYS | Mineralys Therapeutics, Inc. | Director | 1 | $8.76M | -23% | Mar 31 |
| ARTV | Artiva Biotherapeutics, Inc. | Director, 10% Owner | 1 | $194.04K | -53% | Jul 14 |
Get the next Shah Rajeev M. purchase on TelegramFree daily recap of the biggest insider purchases, straight from SEC filings. Real-time alerts for Premium members.
Join free on TelegramAll purchases
| Filed | Stock | Insider | Value | Shares | Price | Since buy | Stake | Trade | |
|---|---|---|---|---|---|---|---|---|---|
| Jul 14 | ARTVArtiva Biotherapeutics, Inc. | Shah Rajeev M. +5Director, 10% Owner | $194.04K | 21,654 | $8.96 | -53% | +0% | Jul 10 | SEC |
| May 6 | COAGHemab Therapeutics Holdings… | Shah Rajeev M. +5Director, 10% Owner | $52.22M | 2,840,429 | $18.39 | +125% | +86% | May 4 | SEC |
| Mar 31 | MLYSMineralys Therapeutics, Inc. | Shah Rajeev M. +4Director | $8.76M | 369,000 | $23.75 | -23% | +7% | Mar 27 | SEC |